196 related articles for article (PubMed ID: 32435610)
1. MiR-155 and MiR-665 Role as Potential Non-invasive Biomarkers for Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
Mohamed AA; Omar AAA; El-Awady RR; Hassan SMA; Eitah WMS; Ahmed R; Khater A; Tantawi OMS; Mohamed AA
J Transl Int Med; 2020 Mar; 8(1):32-40. PubMed ID: 32435610
[TBL] [Abstract][Full Text] [Related]
2. Serum miR-483-5p and miR-133a as Biomarkers for Diagnosis of Hepatocellular Carcinoma Post-Hepatitis C Infection in Egyptian Patients.
Hassan AS; Elgendy NA; Tawfik NA; Elnasser AM
Egypt J Immunol; 2019 Jul; 26(2):31-40. PubMed ID: 31926493
[TBL] [Abstract][Full Text] [Related]
3. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME
Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725
[TBL] [Abstract][Full Text] [Related]
4. Clinical significances and diagnostic utilities of both miR-215 and squamous cell carcinoma antigen-IgM versus alpha-fetoprotein in Egyptian patients with hepatitis C virus-induced hepatocellular carcinoma.
Ali LH; Higazi AM; Moness HM; Farag NM; Saad ZM; Moukareb HA; Soliman W; El Sagheer G; Abd El Hamid SR; Abdl Hamid H
Clin Exp Gastroenterol; 2019; 12():51-66. PubMed ID: 30774409
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes.
Elemeery MN; Mohamed MA; Madkour MA; Shamseya MM; Issa NM; Badr AN; Ghareeb DA; Pan CH
World J Gastroenterol; 2019 Nov; 25(42):6322-6341. PubMed ID: 31754293
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-122a as a non-invasive biomarker for HCV genotype 4-related hepatocellular carcinoma in Egyptian patients.
El-Ahwany EGE; Mourad L; Zoheiry MMK; Abu-Taleb H; Hassan M; Atta R; Hassanien M; Zada S
Arch Med Sci; 2019 Oct; 15(6):1454-1461. PubMed ID: 31749873
[TBL] [Abstract][Full Text] [Related]
7. Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma.
Tat Trung N; Duong DC; Tong HV; Hien TTT; Hoan PQ; Bang MH; Binh MT; Ky TD; Tung NL; Thinh NT; Sang VV; Thao LTP; Bock CT; Velavan TP; Meyer CG; Song LH; Toan NL
PLoS One; 2018; 13(4):e0196081. PubMed ID: 29672637
[TBL] [Abstract][Full Text] [Related]
8. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
[TBL] [Abstract][Full Text] [Related]
9. Circulating microRNA, miR-122 and miR-221 signature in Egyptian patients with chronic hepatitis C related hepatocellular carcinoma.
El-Garem H; Ammer A; Shehab H; Shaker O; Anwer M; El-Akel W; Omar H
World J Hepatol; 2014 Nov; 6(11):818-24. PubMed ID: 25429320
[TBL] [Abstract][Full Text] [Related]
10. Serum miR-96 is a promising biomarker for hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Chen Y; Dong X; Yu D; Wang X
Int J Clin Exp Med; 2015; 8(10):18462-8. PubMed ID: 26770453
[TBL] [Abstract][Full Text] [Related]
11. Improving the Detection of Hepatocellular Carcinoma Using Serum AFP Expression in Combination with GPC3 and Micro-RNA MiR-122 Expression.
Li J; Qiyu S; Wang T; Jin B; Li N
Open Life Sci; 2019 Jan; 14():53-61. PubMed ID: 33817137
[TBL] [Abstract][Full Text] [Related]
12. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
Yu F; Lu Z; Chen B; Dong P; Zheng J
Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970
[TBL] [Abstract][Full Text] [Related]
13. Expression analysis of liver-specific circulating microRNAs in HCV-induced hepatocellular Carcinoma in Egyptian patients.
Mourad L; El-Ahwany E; Zoheiry M; Abu-Taleb H; Hassan M; Ouf A; Rahim AA; Hassanien M; Zada S
Cancer Biol Ther; 2018 May; 19(5):400-406. PubMed ID: 29333940
[TBL] [Abstract][Full Text] [Related]
14. Clinical Value Evaluation of microRNA-324-3p and Other Available Biomarkers in Patients With HBV Infection-Related Hepatocellular Carcinoma.
Zhao L; Yang Q; Liu J
Open Forum Infect Dis; 2021 Jun; 8(6):ofab108. PubMed ID: 34189151
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-215 as a Diagnostic Marker in Egyptian Patients with Hepatocellular Carcinoma.
El Mahdy HA; Abdelhamid IA; Amen AI; Abdelsameea E; Hassouna MM
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2723-2731. PubMed ID: 31554369
[TBL] [Abstract][Full Text] [Related]
16. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
Shaheen NMH; Zayed N; Riad NM; Tamim HH; Shahin RMH; Labib DA; ELsheikh SM; Moneim RA; Yosry A; Khalifa RH
Virus Res; 2018 Aug; 255():77-84. PubMed ID: 30003924
[TBL] [Abstract][Full Text] [Related]
17. Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage.
Lin L; Lu B; Yu J; Liu W; Zhou A
Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):397-404. PubMed ID: 26724963
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of miR-331-3p and miR-23b-3p as serum biomarkers for hepatitis c virus-related hepatocellular carcinoma at early stage.
Sun Q; Li J; Jin B; Wang T; Gu J
Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):21-28. PubMed ID: 31053500
[TBL] [Abstract][Full Text] [Related]
19. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
Mao L; Wang Y; Wang D; Han G; Fu S; Wang J
PLoS One; 2017; 12(9):e0183880. PubMed ID: 28902891
[TBL] [Abstract][Full Text] [Related]
20. Serum miR-483-5p as a potential biomarker to detect hepatocellular carcinoma.
Zhang Z; Ge S; Wang X; Yuan Q; Yan Q; Ye H; Che Y; Lin Y; Zhang J; Liu P
Hepatol Int; 2013 Mar; 7(1):199-207. PubMed ID: 26201634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]